The Latest Breaking News from Jazz

Romeo Langford is reportedly signing an Exhibit-10 deal with the Utah Jazz.

The biotech industry is well-positioned for solid growth due to the growing demand for high-quality treatments for chronic diseases and an aging population. Therefore, it could be wise to invest in fundamentally strong biotech stocks Jazz Pharmaceuticals (JAZZ), Alkermes (ALKS), and Gilead Sciences (GILD), given their solid growth prospects. Read…

SEG Media will use use Kiswe’s cloud-based video solutions and the NBA’s streaming platform to stream Utah Jazz games

The biotech industry is well-positioned for solid growth, thanks to the rising need for high-quality healthcare and the government's push to increase domestic biotech production and research. To that end, buying fundamentally strong biotech stocks Gilead Sciences (GILD) and Jazz Pharmaceuticals (JAZZ) could be wise. However, it could be prudent…

The biotech industry is ascending with growing R&D initiatives, an upsurge in personalized medicine, and enhanced drug formulations, coupled with the incorporation of technological advancements. So, it seems wise to invest in discounted biotech stocks Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ), and Alkermes (ALKS) this month. Keep reading….

Utah wasn’t close to being a playoff team, but with new core players like Lauri Markkanen stepping up to the plate, the squad’s progression is worth a look.

Gaethje could now meet winner of Islam Makhachev and Charles Oliveira

Spartans in Summer League: How Michigan State basketball alums performed this year

Utah’s rookie hung on the rim after a dunk, but he came down on the worst possible spot—his opponent.